tPA vs. TNK, Amp-C and SGLT2 inhibitors! An Alphabet Soup of Therapeutic Updates

Sunday, December 4, 2022

9:00 AM – 10:30 AM

Location: Mandalay Bay South Convention Center, South Seas F, Level 3

CE Credits: 1.50 contact hours

Planned in cooperation with the ASHP New Practitioners Forum
Activity #: 0204-0000-22-205-L01-P
Activity Type: Knowledge-based
Target Audience: Pharmacist
Track: Clinical Development

Learning Objectives:

Discuss the use of alteplase or tenecteplase for acute ischemic stroke.
Cite the recent updates regarding the use of SGLT2 inhibitors for the management of heart failure.
Summarize the 2021 guideline on the treatment of AmpC β-lactamase producing Enterobacterales.

Program Chair(s)

Brooke L. Barlow, PharmD

Neurocritical Care Pharmacist
Memorial Hermann Woodlands Medical Center

Moderator(s)

Brooke L. Barlow, PharmD

Neurocritical Care Pharmacist
Memorial Hermann Woodlands Medical Center

Faculty Member(s)

Brooke L. Barlow, PharmD

Neurocritical Care Pharmacist
Memorial Hermann Woodlands Medical Center
Aeryana Beaudrie-Nunn, PharmD

PGY2 Critical Care Resident
Vanderbilt University Medical Center
Zaynib Hassan, PharmD

Resident
VA Eastern Colorado Health Care System